138 related articles for article (PubMed ID: 7915769)
1. Quinacrine sterilisation revisited.
Kessel E
Lancet; 1994 Sep; 344(8924):698-700. PubMed ID: 7915769
[TBL] [Abstract][Full Text] [Related]
2. India to ban use of quinacrine for sterilisation.
Kumar S
Lancet; 1998 Mar; 351(9107):968. PubMed ID: 11655304
[No Abstract] [Full Text] [Related]
3. FHI quinacrine studies.
Family Health International FHI
Netw Res Triangle Park N C; 1995 Sep; 16(1):27. PubMed ID: 12290470
[TBL] [Abstract][Full Text] [Related]
4. Sterilization needs in the 1990s: the case for quinacrine nonsurgical female sterilization.
Mumford SD; Kessel E
Am J Obstet Gynecol; 1992 Nov; 167(5):1203-7. PubMed ID: 1442967
[TBL] [Abstract][Full Text] [Related]
5. Researchers assess data on long-term safety of non-surgical sterilization method.
Netw Res Triangle Park N C; 1991 Sep; 12(2):26-7. PubMed ID: 12284277
[TBL] [Abstract][Full Text] [Related]
6. India to ban female sterilisation with malaria drug.
Mudur G
BMJ; 1998 Mar; 316(7136):958. PubMed ID: 11645044
[No Abstract] [Full Text] [Related]
7. Quinacrine sterilisations banned.
Rao M
Health Millions; 1998; 24(3):14. PubMed ID: 12293800
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine pellet nonsurgical female sterilization in Wonosobo, Indonesia.
Suhadi A; Soejoenoes A
Fertil Steril; 1997 May; 67(5):966-8. PubMed ID: 9130911
[TBL] [Abstract][Full Text] [Related]
9. Depo-Provera--ethical issues in its testing and distribution.
Potts M; Paxman JM
J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
[TBL] [Abstract][Full Text] [Related]
10. [Contraceptive development--the view from the U.S.A. in the mid 80s].
Potts M; Siemens A; Burton N
Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
[TBL] [Abstract][Full Text] [Related]
11. Family planning in Vietnam.
Feuerstein MT
Lancet; 1993 Jul; 342(8865):188-9. PubMed ID: 8100922
[TBL] [Abstract][Full Text] [Related]
12. The strategic approach to contraceptive introduction.
Simmons R; Hall P; Díaz J; Díaz M; Fajans P; Satia J
Stud Fam Plann; 1997 Jun; 28(2):79-94. PubMed ID: 9216029
[TBL] [Abstract][Full Text] [Related]
13. Risks and rewards: family planners weigh quinacrine.
Diconsiglio JM
Family Plan World; 1994; 4(1):1, 20. PubMed ID: 12318852
[TBL] [Abstract][Full Text] [Related]
14. New methods, increased safety make sterilization popular choice.
Netw Res Triangle Park N C; 1985; 6(4):1-2. PubMed ID: 12340324
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk among women sterilized with transcervical quinacrine hydrochloride pellets, 1977 to 1991.
Sokal DC; Zipper J; Guzman-Serani R; Aldrich TE
Fertil Steril; 1995 Aug; 64(2):325-34. PubMed ID: 7615111
[TBL] [Abstract][Full Text] [Related]
16. FHI's role in search for nonsurgical sterilization.
Netw Res Triangle Park N C; 1994 May; 14(4):26-9. PubMed ID: 12287743
[TBL] [Abstract][Full Text] [Related]
17. Expanding contraceptive options.
Family Health International FHI
Netw Res Triangle Park N C; 1989; 11(1):3-5, 16. PubMed ID: 12283021
[TBL] [Abstract][Full Text] [Related]
18. Family planning in Viet Nam: a vigorous approach.
Feuerstein MT
World Health Stat Q; 1994; 47(1):36-9. PubMed ID: 8085369
[TBL] [Abstract][Full Text] [Related]
19. Quinacrine pellets have potential for simple, low-cost female sterilizations.
Contracept Technol Update; 1994 Apr; 15(4):41-4. PubMed ID: 12318749
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and standardized incidence rates of preclinical cervical pathology among 1,061 women sterilized with transcervical quinacrine hydrochloride pellets.
Dabancens A; Sokal DC; Pruyas M; Rivera M; Zipper J
Fertil Steril; 1995 Aug; 64(2):444-6. PubMed ID: 7615128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
